Abbott's segment revenues 2017-2019

Abbot Laboratories is an international pharmaceutical company headquartered in Chicago, Illinois. As of 2013, Abbott Laboratories was split into two companies: Abbot (medical products) and AbbVie (research-based pharmaceuticals). As of 2019, the medical device segment was the largest segment within the company and generated 12.2 billion U.S. dollars in revenues. Abbot’s diagnostics segment also generated a significant amount for the company with about 7.7 billion U.S. dollars in revenue during that year.

Abbott’s company profile

Abbott Laboratories was founded in 1888 in Chicago, where the company has remained since. The company currently operates in around 160 countries globally, covering therapeutic areas such as diabetes, diagnostics, nutrition and cardiovascular disease. The number of employees at Abbot Laboratories (Abbot and AbbVie) has increased over the last several years. The revenues of Abbott declined around the time the company was split in 2013 but has increased significantly in recent years.

Abbott’s global positioning

Abbot Laboratories is among the top global health companies in many regards. Abbot has been ranked 6th among other biopharmaceutical companies worldwide based on market capitalization. In the meantime, AbbVie, Abbott Laboratories’ spun-off company, was ranked 7th among the top global pharmaceutical companies based on prescription sales. Finally, Abbot Laboratories was ranked third in the total number of approvals and clearances among top medical technology companies.